基本信息
浏览量:48
职业迁徙
个人简介
RESEARCH SUMMARY
Although significant strides have been made in the treatment of Hodgkin's disease (HD) and non-Hodgkin's lymphomas (NHL), major clinical advances have plateaued over despite the development of new chemotherapy regimens and strategies. In an attempt to improve the therapy for lymphomas, we have focused our studies on several promising areas of research:
Strategies to reverse drug resistance;
Schedule dependence of cytotoxic agents and dose intensity;
Development of novel agents, with a focus on T cell toxins;
Identification of clinical mechanisms of drug resistance.
Areas of Expertise
1) lymphoma
研究兴趣
论文共 634 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jigar V Desai, Marissa A Zarakas, Andrew L Wishart,Mark Roschewski,Mariano A Aufiero,Ágnes Donkó,Gustaf Wigerblad,Neta Shlezinger, Markus Plate, Matthew R James,Jean K Lim,Gulbu Uzel,
The Journal of clinical investigation (2024)
Jaewoo Choi,Michele Ceribelli,James D. Phelan,Björn Häupl,Da Wei Huang,George W. Wright,Tony Hsiao, Vivian Morris,Francesco Ciccarese,Boya Wang, Sean Corcoran,Sebastian Scheich,
Cancer Researchno. 6_Supplement (2024): 3913-3913
Andrea J Radtke, Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova, Mark Meerson, Margarita Polyakova, Ilia Galkin, Viktor Svekolkin, Sergey Isaev, Daniil Wiebe,
Cancer cellno. 3 (2024): 444-463.e10
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S424-S425
crossref(2023)
Hematological Oncologyno. S2 (2023): 44-46
Bloodno. Supplement 1 (2023): 4408-4408
Christopher Melani,Kennichi Dowdell,Stefania Pittaluga,Kieron Dunleavy,Mark Roschewski,Joo Y. Song, Sara Calattini, Jun-ichi Kawada,David A. Price,Pratip K. Chattopadhyay,Mario Roederer,Andrea N. Lucas,
LANCET HAEMATOLOGYno. 5 (2023): E346-E358
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn